# Use of the Thrombectomy Device ReVive™ SE in the Acute Treatment of Stroke

> **NCT02971826** · NA · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 1 (actual)

## Conditions studied

- Stroke

## Interventions

- **DEVICE:** REVIVETM SE thrombectomy

## Key facts

- **NCT ID:** NCT02971826
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-30
- **Primary completion:** 2019-06-01
- **Final completion:** 2019-06-01
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02971826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02971826, "Use of the Thrombectomy Device ReVive™ SE in the Acute Treatment of Stroke". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02971826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*